Introduction: Interprofessional collaboration (IPC) is defined as the active collaboration between health workers from various backgrounds to deliver the optimum quality of care to patients. Due to its important health impacts and lack of studies with similar scope in Qatar and the Middle East, this study has been conducted to explore the knowledge, awareness, experience, readiness and, attitude of healthcare practitioners (HCP) working in primary healthcare centres (PHCC) in Qatar towards IPC. Methods: This study is a quantitative, cross-sectional, prospective, web-paper-based questionnaire survey. Surveys were sent to 2500 HCPs who understand English and are working in PHCCs in Qatar. Formulating questions were adopted from two different validated surveys used in previous research. The data were presented as means ± SD and analysed using Chi-square, and analysis of variance (ANOVA) tests. Results: 1415 participants completed the survey with a response rate of 56.6 %. Participants indicated good awareness of the differences between interaction and collaboration, and that the highest collaboration is with physicians followed by nurses and pharmacists. Moreover, participants claimed that they have long experience with IPC. Results of the inferential analysis showed that females have a stronger attitude and readiness towards IPC than males, and physicians seemed to have more readiness towards IPC than other professionals (P<0.001). Discussion: Results of this study showed positive attitudes towards IPC in the region. Main strength of the study is the multiple administration methods (web/paper surveys), and main limitation is the excessive survey length. Further studies are needed to explore attitudes of HCPs in advanced care facilities.
showed an active alpha helix and random coil in the presence and absence of an organic solvent respectively. Discussion: The effects of the prodrug modification on WMR, indicate that the loss of activity originates from charge reduction rather than inhibition of secondary structure formation. The modification of AMPs as prodrugs could reduce their toxicity and address the clinical limitations associated with their therapeutic indices. The present work provides further information on AMPs conformational interactions with both human and microbial membranes and contributes to elucidate their mechanism of action.
A4:
Correlation of matrix metalloprotease activity with clinical outcome in cystic fibrosis via the CF-ABLE score Isha Bagwe 1 , Oliver McElvaney 2 , Emer Reeves 2 , Noel McElvaney Introduction: Despite current glioblastoma treatments, 90% of patients survive less than two years often due to therapeutic-resistance, hence, there is an ever-growing need for novel therapies. Quinacrine, a former antimalarial drug has had success linked to autophagy in other malignancies. It has a known side effect profile and current drug approval, so it could be re-purposed quickly making it an ideal candidate. We aimed to investigate the effect of quinacrine on cell viability and autophagy induction. Methods: Cell viability and autophagy induction assays were performed to assess cytotoxic activity in U87-MG and SVG-p12 cell lines when compared to cisplatin under normoxic and hypoxic conditions. Results: The treatments reduced cell viability over a 72-hour period in a concentration and time-dependent manner. The effect of quinacrine was not significant when compared to cisplatin. The IC50 values indicated that quinacrine was not affected by oxygen concentration, but cisplatin was, with reduced efficacy in hypoxia. Autophagy assay results suggested that cisplatin significantly induced autophagy in both cell lines. Whereas, quinacrine and rapamycin (the positive control) appeared to not induce autophagy. Discussion: Cell viability results suggested quinacrine has a similar efficacy to cisplatin and therefore has potential as a glioblastoma therapy. The IC50 values indicated that as quinacrine efficacy was unaffected in normoxia and hypoxia that it may be able to overcome therapeutic-resistance as this resistance is associated with hypoxic tumour regions. The autophagy assay results suggested either quinacrine and rapamycin did not induce autophagy, or that the untreated cells had higher autophagy induction due to cellular stress.
A7:
Using YouTube for learning cardiac embryology -what quality of videos are there to view? Niveta Ramakrishnan 1 , Jane Holland 2 , Teresa Pawlikowska 2 , Ruth Matthew how their form changes in the fourth dimension -time. Where do students generally find these visuals? Methods: Methods A systematic literature review was performed in PubMed and Embase, to identify any references examining the use of YouTube in teaching or learning cardiac embryology. While an initial 224 references were retrieved for review, and a further 63 references identified through subsequent targeted searches, we found no papers examining this question, and only one other related study examining the quality of YouTube videos concerning gastrointestinal neonatal (and embryological) conditions. Next, YouTube.com was searched using 12 search terms such as "cardiac embryology" and "atrial septation". A total of 1200 videos were retrieved; some video urls were retrieved under two or more of the search terms (n = 370) and were excluded as "duplicates". A further 456 videos were excluded under 13 specific criteria including language, non-human or non-cardiac embryology. The remaining 374 videos were then qualitatively evaluated using criteria that Azer et al and Chan et al develop in their respective studies of e-Learning resources. While the qualitative evaluation of the identified YouTube videos is still ongoing, some initial findings and observations may be reported. Results: Results Content control on YouTube, with regard to copyright or explicit imagery, is still imperfect. Five videos identified through our initial searches in June 2018 were subsequently removed form YouTube over the course of the summer for issues including content infringement, and our team also excluded 26 videos from our qualitative analyses, as they were duplicates of other, original videos identified under our search terms. Although we identified 49 videos showed operative procedures or human material, none contained an explicit ethical statement regarding the use of these images. Furthermore, only 10 of these videos included a warning about the nature of the images, such as a graphical advisory or age-restriction. Discussion: Discussion and conclusions To summarise findings to date, while there are certainly videos of use to medical students studying cardiac embryology present on YouTube, intuitive search strategies will also identify many videos with irrelevant content and of variable quality. Some, which claim to be educational, may score very low on the rating scale, while some which have been very simply shot and edited, with minimal resources, are quite excellent. Introduction: In Multiple Sclerosis (MS), disease progression is associated with a pro-inflammatory macrophage phenotype, including proinflammatory exosome secretion. A micro RNA, miR-155 is thought to be involved in the regulation of these pathways, however the mechanism is unclear. Identification miR-155 targets in this secretory pathway will aid in understanding the function of miR-155. Consequently, this could highlight therapeutic targets that may be of clinical significance in patients suffering from MS and other autoimmune conditions. Methods: We stimulated RAW 264.7 cells, a macrophage cell line, with LPS, LPS and IL-10 and IL-10 alone and recorded changes in Rab11fip1 transcription and miR-155 expression vie real time PCR. Results: At 4 hours of stimulation,: Rab11fip1 transcription increased 4.05-fold with LPS and 3.13-fold with LPS and IL-10. miR-155 expression increased 2.51-fold with LPS and 1.36-fold with LPS and IL-10. Discussion: The induction of miR-155 expression by LPS and increase in Rab11fip1 transcription in addition to the relative inhibition of miR-155 and Rab11fip1 when co-stimulated with IL-10 supports a relationship between the gene and the miR-155. This relationship can show that miR-155 regulates Rab11fip1 and can be a method by which miR-155 influences the secretion of exosomes. This property may be of interest in developing novel therapeutics for MS. Introduction: Low-grade glioma (LGG) is the most common pediatric central nervous system tumour. Spinal tumours are rare and difficult to treat, with the treatment of spinal LGG (SLGG) being controversial. The Canadian Pediatric Brain Tumour Consortium (CPBTC) undertook a retrospective review of SLGG to primarily identify prognostic factors for patients. We hypothesize that five-year progression free/overall survival of SLGG will be better than published data on intracranial LGG, with Chemotherapy/Radiation therapy showing similar efficacy. And there being a trend towards less aggressive therapy overtime. Methods: With ethics approval, a retrospective chart review was performed. Patients with primary SLGG under 18, treated at BC Children's Hospital between 1990-2015 were included. Data collected includes date/age at diagnosis, gender, known tumour predisposition syndrome, symptoms, time to imaging, pathology, treatment, postoperative symptoms, neurological recovery, study enrolment, recurrence/progression, treatment of recurrence, and if died of disease. Descriptive statistics were performed. Results: : Results show, 28 subjects with SLGG, 89% are alive. Metastatic disease was seen in 3 (10.7%). Only 32% were able to have a gross total resection (GTR). 57% of subjects had recurrent disease. The most common presenting complaint was pain (64%), followed by weakness (54%) and scoliosis (36%). The majority (54%) had over 6 months of symptoms prior to imaging being performed. Discussion: Children with spinal tumours have good outcomes, despite a low numbers of GTR. Disease recurrence requiring further surgery, chemotherapy/radiation therapy is common. Children with back pain, weakness or scoliosis should have prompt neuroimaging, as there was a delay in diagnosis. Introduction: Women with substance use disorders who have unintended pregnancies face unique challenges. A common strategy for preventing unintended pregnancies among these women is to increase their use of long acting reversible contraception (LARC). This study assessed the pregnancy history and contraceptive use of women attending Cork-Kerry Community Healthcare for opioid substitution therapy, and their access to contraceptive services. The need for a contraceptive service within the addiction services at Cork-Kerry Community Healthcare was evaluated. Methods: The study utilized a cross-sectional survey administered by healthcare providers to 39 women ages 18-50 attending Cork-Kerry Community Healthcare for opioid substitution therapy. Results were compared to Irish national data on pregnancy history and contraception use. Results: 79% of participants had unintended pregnancies, and 23% had 3 or more unintended pregnancies. Of the participants' children, 35% lived with their mother, 37% lived in care, and 24% lived with another family member. 31% of participants had never used LARC. 22.5% of participants reported never having received information on pregnancy prevention and 25.6% reported never having received information on STI prevention. 92% of participants reported that they would use a contraceptive service if it were provided within the addiction services at Cork-Kerry Community Healthcare. Discussion: This study highlights the need to increase contraceptive services for women attending addiction services at Cork-Kerry Community Healthcare. Addiction services are ideal locations to also access contraceptive services because service users already attend these clinics frequently for treatment, and thus have continuity of care with healthcare providers.
A9: Spinal

A10:
A12:
Assessment of a stress-reduction intervention for pregnancyrelated pelvic girdle pain: a pilot study Introduction: Pregnancy-related pelvic girdle pain (PPGP) refers to pain in the lumbosacral, sacroiliac and/or symphysis pubis joints. PPGP is present in nearly 20% of pregnancies, and in up to 10% of patients, may persist post-partum for years. The aetiology is poorly understood, but stress during pregnancy is predictive for persistent post-partum pain. Evidence for the efficacy of current treatments has been limiting and conflicting, and treatment efforts often unsuccessful. This study aims to assess the effectiveness of a stress-reducing intervention on pain symptoms associated with PPGP. Methods: 15 women with PPGP were recruited from Cork University Maternity Hospital (CUMH). Participants received two, one-hour sessions; information on the stress response, gentle exercises, and confidence-building counselling were provided. Before and after each session, salivary samples were obtained and cortisol was quantified with ELISA. Participants completed the Roland Morris Disability Questionnaire, Cohen Perceived Stress Scale, Stait Trait Anxiety Questionnaire, and the number of steps possible in 60 seconds was recorded. Results: 15 participants completed the first intervention session, of which 7 completed both sessions. The questionnaire results and steps per minute indicated the intervention led to a significant improvement in anxiety, pain, stress and mobility. A significant decrease in salivary cortisol was measured after the two sessions, compared to the initial baseline measurement. Discussion: The potential benefit of a stress-reducing intervention for women experiencing PPGP has been illustrated by this study, through reducing pain, stress, and anxiety while concurrently improving mobility. This data will support a feasibility trial study, followed by a multi-centre clinical trial. Introduction: Neuroblastoma is an embryonal tumour originating from the peripheral sympathetic nervous system. MYCN amplification (seen in about 22% of cases), associated with poor patient survival, is one of the strongest determinants of clinical outcome. This project aimed to characterise the MYCN interactome in the BE(2)-C MYCNamplified neuroblastoma cell line, and identify novel targets for the therapy of neuroblastoma. Methods: Initially, protein-protein interaction partners of MYCN were identified by MYCN co-immunoprecipitation coupled to mass spectrometry. Analysis of this data by String and Ingenuity Pathway Analysis (IPA) software determined the most altered pathways associated with MYCN amplification, one of which is mTOR. The effect of an mTOR inhibitor, Rapamycin, on BE(2)-C cells alone or in combination with aurora kinase inhibitors Tozasertib and Alisertib was determined using microscopic phenotypic observation and cell death analysis by flow cytometry. Results: 96 proteins were identified as MYCN interactors in BE(2)-C cells. IPA identified that the MYCN binding proteins participate in mTOR signalling and regulation of the cell cycle. All tested monoand co-treatments decreased proliferation and increased cell death compared to the control. Aurora kinase inhibitors increased differentiation more than Rapamycin alone and co-treatments more than mono-treatments. Alisertib and Rapamycin co-treatment(48.75%) increased cell death compared to Alisertib(36.6%) or Rapamycin(10.65%) alone while there was no marked difference between Toszasertib mono-and co-treatments. Discussion: Targeting signalling pathways which orchestrate MYCN's oncogenic functions is an effective way to inhibit neuroblastoma growth. Further validation in pre-clinical trials is necessary to verify the synergistic potential of these new drug combinations. Introduction: Cancer is one of the leading causes of death worldwide. Much research has gone into prevention, early diagnosis and development of anti-cancer treatments. However, there is little understanding of proliferation and resistance in cancer cells as well as each individual patient's response to anticancer agents. Patient derived xenograft (PDX) is the engrafting of a patient's tumour cells into immunodeficient mice, while maintaining the histopathological, genetic and phenotypic integrity of the original tumour. By doing this, we are able to establish clinically predictive models of human cancers to better personalise treatment options. Methods: Primary tumours are excised from patient and transplanted into immunodeficient mice. Tumours >15mm3 in mice are then excised and transplanted to the next generation. Tumour cells from different generations of immunodeficient mice are stained with H&E and immunohistochemical markers (EPCAM, CDX2). Cell morphology and molecular differences are evaluated between the different generations of the PDX model. Results: Results show that the PDX models for both patients were successfully established. Histopathology and immunohistochemistry of the tumours showed similarities between the patient's original tumour and the subsequent generations in the PDX model. This demonstrates that the tumour grafts conserved the genotypic integrity of the patient's tumour. Discussion: PDX models can be used in basic cancer research involving characterisation, tumorigenesis, and metastasis. Using the PDX model as a cancer avatar for the patient, we are able to do preclinical and co-clinical studies on drug screening, future drug development and biomarker discovery.
A13:
A14:
A16:
Creating a novel virtual/electronic whiteboard (vWB) Introduction: There are barriers within hospitalised care that prevent the transition of inpatients with dementia to best possible dispositions. We hope that the creation of the vWB and the data being collected through the vWB and surveys, as well as the feedback from the DCCC staff, will help us enhance the vWB tool and determine the inhibiting factors that provoke these delays. Results: Fifty percent of patients received NP treatment, 15% received opioids, and no patients received SMRs. NP-only and pharmacologic (PH) management rates were similar among GMS and non-GMS patients. NSAIDs were prescribed more frequently to GMS patients while opioids were prescribed more frequently to non-GMS patients. Discussion: Only 50% of patients received NP therapy as first-line management yet this should be considered for all patients before PH management. SMRs should be considered in addition to NSAIDs when NP management proves inadequate. A reluctance toward opioid prescription should be adopted as opioids are not recommended in the ACP guideline.
A18:
The role of lymphoscintigraphy in sentinel lymph node biopsy for breast cancer: An audit of 100 lymphoscintigrams in a tertiary Irish Introduction: Sentinel lymph node biopsy (SLNB) has frequently been demonstrated to accurately stage axillary lymph nodes in breast cancer. When performed, preoperative lymphoscintigraphy (LSG) is commonly used as a complementary modality to enhance the identification of sentinel lymph nodes (SLNs). However, the clinical significance of LSG remains debated. Methods: 100 breast and axillary lymph nodal status were evaluated retrospectively. Data was obtained from Beaumont Hospital online databases and medical records. 97 patients were assessed by LSG using radioisotope and subsequently by SLNB. Three patients had bilateral nodal assessments. Results of the LSG, SLNB and histology report were analysed and compared on Microsoft Excel. Results: LSG identified SLNs in 90 cases (90%). SLNs were identified surgically in all cases with a negative LSG (n=10). The mean number of nodes identified by modality was 1.39 by LSG, 1.36 by surgery, and 2.4 by histology. 27 cases were positive for nodal metastases. The number of nodes on LSG was identical to surgery and histology in only 49% and 35% of cases, respectively. Discussion: LSG does not have a significant role in the identification of SLNs. Moreover, the result of LSG does not accurately reflect the number of nodes identified surgically or histologically.
A19:
Water, sanitation and hygiene and the risk of malnutrition in Introduction: It is increasingly apparent that water, sanitation, and hygiene are important determinants of malnutrition in children besides that of food availability. This study draws an association of water, sanitation and hygiene (WaSH) as potential risk factors for stunting, wasting and growth faltering among 2-5-year-old Indian children. Methods: Nationally representative data on 90,867 children from Indian National Family Health Survey NFHS-4 was analysed for determinants of malnutrition based on UNICEF conceptual framework. Statistical analysis involved descriptive and univariate regression to select 20 variables comprising of maternal, child and environmental factors to be included in the final multivariable models-each for stunting, underweight and wasting and multiple logistic regression to determine associations. Results: With a 15-36% reduction in prevalence of different forms of malnutrition, access to toilets and safe disposal of child's feces emerge as pertinent determinants of malnutrition in children, sanitation also being associated with lowering of odds of stunting by 11%, underweight by 10% and wasting by 7%. Adjusting for potential confounders, water-related factors were however not significantly associated with risk of malnutrition. No interaction was observed between water and sanitation. Discussion: In the given setting, among all wash indices, sanitation emerged to be the single modifiable entity associated with significant reduction in the risk of both acute and chronic malnutrition with greater impact compared to water. Concluding, the present study establishes the magnitude of impact effective integration and robust implementation of WaSH interventions with other nutrition specific measures can have in national programmes for primary level prevention and ultimate elimination of malnutrition.
A20:
Novel blood biomarkers for risk stratification, prognosis, and mechanistic insight in children with severe TBI Alexandr Magder 1 , Jamie Hutchison Introduction: Traumatic Brain Injury (TBI) is the most common cause of acquired disability in children. The molecular mechanisms are not well understood and acutely clinicians are often unable to prognosticate. We hypothesized that low abundance proteins, measured in blood, would relate to mechanisms of secondary brain injury and be associated with long-term global neurological outcome. Methods: Demographic, injury severity and physiologic data was collected from 210 pediatric patients. 112 (53%) of these patients had severe TBI defined as a Glasgow coma scale (GCS) of ≤ 8 on admission. We then chose 8 of these children with blood samples drawn within 24 hours of TBI and an unfavorable outcome (severe disability or death) at 6 months following TBI and matched each using GCS, age and sex to 8 other children with a favorable outcome (normal or mild disability) at 6 months post-TBI. Low abundance proteins were measured using untargeted mass spectroscopy. Scaffold Q+ proteomic software was used to compare semi-qualitative differences in serum concentrations of identified proteins focusing on statistical differences between the two experimental groups.
Results: Twenty-four proteins were statistically different between the favourable and unfavourable group, including metabolic, antioxidant, and vasoactive proteins. Six were consistently found in poor outcome patients and one unfavourable in positive outcomes, which corroborated mechanistic evidence in previous literature. Discussion: These insights may lead to new molecular therapies and have potential to greatly improve clinical decision making and risk stratification models for clinical trials.
A21:
Elucidating the role of FKBPL in the IL-6/STAT3 signaling pathway Introduction: FKBPL is an anti-cancer protein that targets CD44 receptors to inhibit cancer angiogenesis and stemness. Based on the active region of FKBPL, a biological drug was developed and has successfully completed Phase I clinical trials (EudraCT No: 2014-001175-31) . STAT3 is known to interact with CD44 and its dysregulation is associated with increased cancer tumourigenesis, metastasis and stemness. We performed a knockdown of FKBPL gene expression in ovarian (OVCAR3) and breast (MDA-MB-231) cancer cell lines to investigate the effect this had on the IL-6/STAT3 signaling pathway. Methods: OVCAR3 and MDA-MB-231 cells were transfected with scrambled or targeted FKBPL siRNA for 48 hours. Following RNA extraction, cDNA was analysed using an RT2 PCR Profiler Array containing 84 genes related to IL-6/STAT3 signaling. A minimum threshold of 2-fold was chosen as a cut-off to identify genes of interest. Candidate genes chosen for validation were measured by RT-qPCR (N=4). Results: CCL4, CXCL10 and TNFRSF1B were upregulated while PIM1 and LIFR were downregulated in OVCAR3 following FKBPL siRNA knockdown. JAK3, IL6R, EGFR, BCL2, IL4, CCL3 and TLR4 were upregulated while IL6 and IL11 were downregulated in MDA-MB-231 following FKBPL knockdown. 5 genes from the MDA-MB-231 array have been re-validated by qPCR (N=4). EGFR (1.89, p<0.01), BCL2 (1.96-fold, p<0.01) and TLR4 (1.39-fold, p<0.05) were upregulated while IL6 (-4.16-fold, p<0.001) and IL11 (-1.89-fold, p<0.05) were downregulated following FKBPL knockdown. Discussion: This data highlights a novel interaction between FKBPL and the IL-6/STAT3 signaling pathway. Thus, FKBPL may elicit its known anti-cancer activity through a modulation of the IL6/STAT3 signaling pathway. Introduction: High Endothelial Venules (HEVs) are specialized blood vessels that support the migration of naïve lymphocytes from the bloodstream into secondary lymphoid organs. A regulated sequence of adhesive interactions are mediated by different adhesion molecules that allow binding of lymphocytes to surface of HEVs and are critical for lymphocyte entry into lymph nodes. HEVs develop in nonlymphoid organs during chronic inflammation and are associated with increased lymphocyte infiltration. Recently, HEVs have been observed in solid, vascularized cancers such as breast cancer and melanoma and their presence is correlated with improved patient outcomes. It is proposed that newly formed HEV promote anti-cancer immunity by recruiting lymphocytes into the cancer. The aim of this project is to determine whether HEVs develop in mouse models of cancer immunotherapy Methods: Important murine HEV markers (e.g. GlyCAM-1) were selected and the appropriate primers designed. RNA was extracted from untreated mouse lymph nodes and spleens positive and negative controls. Isolated RNA was analysed for impurities before cDNA synthesis was carried out. RT-PCR was used to analyse cDNA for the selected genes and. Beta-2-microglobulin was used as control. Results: The analysis of the RT-PCR showed an increased amplification for GLYCAM-1 cDNA, specifically in the lymph node samples, as HEVs not present in the spleen. However, significant results were not seen for other HEV markers or endothelial markers. Discussion: In conclusion, GLYCAM-1 was considered an important marker for detecting HEVs. The next step is to analyse tumours from mice that have had immunotherapy. Introduction: Post-operative VTE remains one of the leading complications and causes of mortality in colorectal surgery patients with cancer. While there is evidence that continuation of VTE prophylaxis beyond the hospital stay can reduce overall incidence of VTE in select groups of surgical patients, local hospital guidelines for prescribing post-discharge prophylactic medication to prevent VTE vary in practice. The aim of this project was to develop an evidence-based protocol for post-discharge VTE prophylaxis on colorectal cancer patients undergoing surgical resection at St. Michael's Hospital, Toronto. Methods: The project consisted of a literature review surrounding VTE prophylaxis in cancer patients, a chart review of 100 cancer patients undergoing colorectal surgery to determine compliance with best practice, and possible implementation of a new thromboprophylaxis protocol. Results: Current guidelines recommend 30-day post-operative thromboprophylaxis for cancer patients undergoing major abdominal or pelvic surgery. After review of the 100 cases, 21 cases were excluded from analysis because they did not have a laparotomy or laparoscopic procedure or they were on anticoagulation therapy at time of/ during admission. Only 2 of the 79 remaining cases (2.53%) were prescribed post-discharge thromboprophylaxis. Discussion: This demonstrates a gap in the use of recommended guidelines for the prevention of VTE in colorectal resections for cancer patients. A protocol for implementation of post-discharge VTE prophylaxis in cancer patients undergoing colorectal surgery at St. Michael's Hospital, Toronto was developed and is in the beginning stages of implementation. This knowledge translation approach will serve to improve outcomes in patients undergoing colorectal cancer surgery at the Institution. Introduction: Substantial evidence justifies great caution in the use of long-acting sulfonylureas in the treatment of Diabetes Mellitus, in particular amongst frail patients. Deprescribing is the systematic discontinuing of drugs where existing or potential harms outweigh existing or potential benefits. This study sought to identify cases of long-acting sulfonylurea use at a large, urban, community teaching hospital and utilise evidence-based deprescribing tools to rectify cases where risks outweighed benefits. Methods: During August 2018, all patients admitted to MGH between July 1st 2017 and August 1st 2018 and prescribed Glyburide/ Glibenclamide were identified. These were all followed up to ascertain their current medication regimen. Following consultations guided by deprescribng guidelines, individualised deprescribing recommendations were either carried out directly by project team physicians or forwarded to patients' family doctor and community pharmacy. Secondary process measures looking at deprescribing behaviour in MGH were also analysed. Results: 30 patients were identified as being on Glyburide/Glibenclamide during the studied period and eligible for follow up. Of these, 17 (57%) had been appropriately deprescribed prior to the study. All 13 remaining patients were provided with a deprescibing recommendation, of which 4 were carried out by project team physicians and 9 were forwarded to patients' primary physician. Among reviewed patients, no readmissions were attributed to deprescribing recommendations made. Discussion: Deprescribing initiatives focusing on a specific drug or drug class in a community hospital are feasible. A supportive culture, collaboration with Pharmacist colleagues and EMR are key enablers.
A22:
A23:
Reviewing physicians' decisions to proactively deprescribe may highlight other levers to enhance good deprescribing behaviours.
A25:
Correlation between syndromic surveillance data and rainfall in the Caribbean using endemic channels Sumara Jaimungal 1 , Avery Hinds Introduction: Many diseases endemic to Caribbean countries are monitored regionally via syndromic surveillance. Endemic channels (EC) are being used to supplement EARS (early aberration reporting system) as a means of differentiating anticipated seasonal influxes from true outbreaks in order to be more efficient at in response coordination. The aim of this study is to determine, graphically using endemic channels, any correlation between with the number of cases of syndromes reported and rainfall. Methods: Monthly rainfall data was collected from 13 Caribbean member states (CMS) for the period 2011-2017. This was compared with monthly averages of cases for each of the 8 years, for 3 defined syndromes: fever and respiratory; gastroenteritis; undifferentiated fever from the 13 CMS. ECs were constructed utilizing the geometric mean method. Involved using population data for each year to find rates per month then a logarithmic transformation to find plot values. 8-year rainfall averaged per month was then superimposed on each EC. Results: Gastroenteritis had an inverse relationship with rainfall. Fever and respiratory, as well as undifferentiated fever, did not have any clear relationship with rainfall. Discussion: These findings suggest that during monthly periods of heavy rainfall, reported cases of gastroenteritis are lower than during periods of decreased rainfall. Investigations into food consumption behaviour during periods of decreased rainfall will be useful in determining how the transmission is increased. This information will be valuable in establishing public health campaigns aimed at educating the population in gastroenteritis mitigation strategies as a means of decreasing the burden of the disease. Introduction: The steroid hormones estrogen and androgen play a vital role in cell growth and death. Serum and glucocorticoid regulated kinase 3 (SGK3) is a target gene of both estrogen and androgen receptors. We continued on the work that has been previously done in uncovering the relationship between ERa, AR and SGK3 in breast cancer treatment. Methods: First, Human breast cancer cell lines (MCF7 Aro, MCF7, LetR, ZR75.1 and ZRR) were cultured to evaluate the effect of steroid hormone on SGK3 expression. Next, RNA extraction was performed with Qiagen Rneasy column protocol (Exception was made in step 14). Then, Western blotting protocol was applied. Finally, cell proliferation assay was measured by MTS. Results: AI-sensitive cells had higher levels of SGK3 expression than the resistant except MCF7Aro, which showed almost no expression. All treatments in this experiment affected LetR cell survival and growth with estradiol (E2) having the greatest effect on the cell line. Discussion: Increased quantity of SGK3 in AI-resistant cells was expected. However, our results demonstrated a decrease in protein levels. This could be due to numerous reasons. For example, we used translation to quantify the levels of SGK3 rather than transcription.
Steroids showed a positive impact on LetR proliferation. However, due to the three days limitation we cannot predict the response after that time frame. *These authors contributed equally to this work Introduction: Medication errors are a not uncommon and potentially preventable cause of adverse outcomes in hospitalised patients. Insulin is a high risk medication with the potential to cause serious harm if not administered correctly. The aim of this study was to examine current insulin prescribing practices in Connolly Hospital Blanchardstown (CHB) with the intention of developing a quality improvement plan should prescribing errors be identified. Methods: A hospital-wide point-prevalence audit involving all patients in the hospital treated with insulin was conducted over a one week period. This involved reviewing the medication kardex and bedside folder of patients on all types of insulin including: basal, bolus and mixed insulins, sliding scale and intravenous insulin. A number of measures were assessed relative to the expected prescribing standards, including the use of brand name, whether the dose was stated, the use of "units". Results: During one week, a total of 232 patients were captured across 12 wards with 18 patients identified receiving insulin (8%). A total of 58 errors were identified among the 41 insulin prescriptions, with an average of 1.4 errors per prescription. The most frequent error involved the lack of documentation on the main kardex that additional insulin prescriptions (sliding scale (sc), IV) were in place. Discussion: Analysis of the insulin prescribing suggested that prescribing errors are common. The reasons for the errors are probably complex but a number of system failures could have contributed. An insulin-specific kardex will be designed to reduce the frequency of such errors. Introduction: An Abdominal advancement flap is often used as one of methods of the breast reconstruction with prosthetic materials and dermal matrix after radical mastectomy. We modified the old method of abdominal advancement flap and compared the patients treated with classic and new method. Methods: An abdominal advancement flap is a flap that is pulled up using the skin and the subcutaneous tissue that was under the original inframammary fold and creates the shape of the lower part of the breast by making a neo-inframammary fold. In this new modified method the fixation of the mobilized skin is realized by using a longterm absorbable material installed into the subcutaneous region within the range of the footprint of the new breast which is fixed transpectorally by specialized skeletonized needles. We monitored and compared two groups of patients. In the first reference group of 11 patients during the breast reconstruction was used expander/implant and acellular dermal matrix. In the second group of 11 patients was used besides standard completions also new method of abdominal advancement flap.
A27:
Results: Using this modified method of abdominal advancement flap, we discovered its relation with initial expansion volume which was 44 percent bigger than at classical method. In the first group of pacients we registered three post-operative complications and in the second group, we noticed two complications. Discussion: This method has more aesthetic and functional effect with the minimal morbidity of the donor site compared to the "conventional method". This method leads to aesthetically better formed lower part of new breast.
A29:
An observational study of the utility of BRAF and MEK combination therapy in metastatic melanoma in a regional cancer Introduction: Trametinib (MEK inhibitor) combined with Dabrafenib (BRAF inhibitor), targeted therapy for BRAF mutated metastatic melanoma, was introduced in Ireland in 2012. The clinical outcomes of these drugs have not been evaluated in an Irish population. The relationship between toxicity and outcome has to date not been studied. Methods: A retrospective chart review of all patients (n=41), treated with dabrafenib alone or in combination with trametinib from May 2012 to September 2018 was carried out. Clinicopathologic variables were recorded. The clinical course of all patients was examined in detail. Treatment outcomes were measured using progression free survival (PFS), overall survival (OS) and objective response rates (ORR). Results: 39% of patients experienced grade 3 or greater of a side effect, necessitating a dose reduction. The median PFS of patients who experienced side effects was 12.29 months (95% CI 4.045 to 20.535) versus 5 months(95% CI 2.215 to 7.785) in patients who didn't experience side effects (p=0.003). The median PFS for patients who had their dose reduced due to side effects was 16.55 months (95% CI 0.426 to 32.674) versus 5.520 (95% CI 3.972 to 7.068) in those whose doses remained the same (p=0.024). The ORR among all patients was 82.9%. When patients with brain involvement (n=12) were removed, the median PFS was 12.35 months (95% CI 0.42 to 24.280) and median OS was 18.19 months (95% CI 13.412 to 22.968). Discussion: The median OS of 18.19 months in patients without brain metastases is lower than the clinical trials median of 25.6 months. This is likely due to our heterogenous population. Our results highlight a statistically significant relationship between toxicity and PFS. A similar situation has been reported with immunotherapy. These findings may impact clinical practice. Introduction: Clostridium difficile (C.diff.) is a Gram-positive, anaerobic bacillus, widely spread in the human environment. In the last decade, the incidence and severity of Clostridium difficile infection (CDI) have been increasing, making this particular disease one of the most significant nosocomial infections. Notable risk factors include antibiotic use, advanced age, previous hospitalization. The patients often present with multiple comorbidities, which makes management challenging. Methods: The study analysed 154 patients (mean age 77) who died diagnosed with CDI in the University Hospital in Krakow, Poland. The focus was on the complication rate, factoring in comorbidities, risk factors and antecedent antibiotic treatment type. Data was collected using standardised forms and statistical analysis was used where applicable. Results: All patients had pre-existing risk factors for CDI in some form. 82,5% (127 out of 154) patients had been treated with antibiotics before developing CDI. Almost half (47%) had been treated with an immunosuppressant, most commonly steroidal. Among the most common pre-existing conditions was diabetes (32%, 49 out of 154 patients). Complications recorded in medical documentation included a high rate of pneumonia (19,5%, 30 patients), AKI (5,8%, 9 patients) and numerous others. Discussion: The epidemiological data of patients who died in the course of CDI paints a picture of a fragile, aged population with a staggering rate of risk factors for CDI, numerous comorbidities and complications. The high rate of pneumonia could be particularly worrying for patients such as those and more emphasis should be put on its prevention and fast diagnosis.
A31:
Retrospective study of competing risk model in screening for preeclampsia at 11-13 gestational weeks Sorana Manuca 1 , Dragos Nemescu Introduction: Preeclampsia (PE) affects about 2-5% of pregnancies and is a major cause of maternal and perinatal morbitidy and mortality. Our aim was to study the risk distribution of PE calculated in our local population at 11-13+6 gestational weeks by means of the FMF (Fetal Medicine Foundation) algorithm which combines a priori risk from maternal characteristics with uterine artery pulsatility index (UtA-P), serum pregnancy-associated plasma protein-A (PAPP-A), placental growth factor (PlGF) and mean arterial pressure (MAP). Methods: Data of 1037 singleton pregnancies at 11+0 to 13+6 weeks' gestation in women who underwent aneuplodiy screening at our department from December 2009 to October 2017 was analyzed using Astraia and SPSS. Maternal risk factors were recorded, MAP and UtA-PI were expressed as multiples of the median (MoM) and log transformed to make their distribution Gaussian. Twins, major anomalies, aneuploidies and incomplete data were excluded. Results: Out of 124 (14%) nulliparas with high risk (>1/100) for preeclampsia before 37 weeks, we had 94 (75%) available outcomes. These included 8 (9.5%) with preeclampsia, 17 (18%) with gestational hypertension and 5 (6.4%) with fetal growth restriction. From 732 (85.6%) cases with low risk (<1/100) for preeclampsia, we had 357 (49%) available outcomes with 2 cases of severe PE. The risk for PE before 34 weeks was >1/100 in 101 (9.7%) cases and ≤1/100 in 936 cases (90.3%). Discussion: Screening by means of FMF algorithm yielded better results at identifying the risk groups in our population than screening by maternal factors alone.
A32:
The expression of cannabinoid proteins paths in mammalian tissue Piotr Przybycień 1 , Piotr Przybycień Introduction: The endocannabinoid system (ECS) is a natural system composed of endocannabinoids and their receptors. It is disseminated throughout the mammalian central nervous system and peripheral organs. The major ligand of the CB1-receptor is AEAanandamide. This system is involved in many processes of the mammalian body, such as pain, sensation, mood, appetite, fertility or pregnancy. In this study, we analysed CB1-R and CB2-R levels in various parts of the CNS and female reproductive system. Methods: The first stage of the study was organ extraction from lab mice. Subsequently, each sample was homogenized and centrifuged. We measured the total protein concentration and performed Western Blot assays on the extracts. Finally, the receptors were visualized using chemiluminescence. A detailed comparison of the results in tested tissues was performed. Results: The study focused on two types samples of CNS tissue and two types of female reproductive tissue. A higher concentrations of the receptors were noted in the encephalon compared to the cerebellum and in uterine tissue compared to the oviduct. Receptors concentrations in the brain and uterus were similar. Discussion: We confirmed a variable concentration of CB-1 receptor and CB-2 receptor in murine tissue. The levels of expression of these receptors in various parts of both systems are reflected in their function.
A33:
The antimicrobial potential of RNA G- Introduction: RNA G-quadruplexes (RG4s) are stable structures that are unfolded in mammalian cells. In bacteria, they remain folded. Hence bacteria have undergone evolutionary depletion of endogenous RG4s possibly because they impair bacterial growth. The aim was to compare the potential antimicrobial activity of two RG4s against E.coli and S. aureus versus gentamicin and oxacillin. Methods: Duplicate suspensions of E.coli (ATCC 25922) and/or S.aureus (ATCC 2160), set to a 0.5 McFarland Standard, were treated at 37oC overnight ±30% ethanol (positive control), 0.39-50μg/mL gentamicin or oxacillin (n=3) or 1.95-250μg/mL RG4s (n=1), specifically G3U (5'-UUU-GGG-UGG-GUG-GGU-GGG-3'), G3A2 (5'-UUU-GGG-AAG-GGA-AGG-GAA-GGG-UUU-3') or a control RNA (5'-UUU-GAG-UGA-GUG-AGU-GAG-UGA-GUU-UU-3') that does not form a G-quadruplex. The Miles and Misra method was used to determine the minimal inhibitory concentration (MIC) by calculating the number of colonyforming units per mL (CFU/mL). Competent E.coli cells (n=3) were prepared to increase their ability to uptake RG4s. These were transformed with 250μg/mL RG4s and CFU/mL were calculated. Results: The MIC for (i) gentamicin against E.coli was 0.78-0.39μg/mL, (ii) oxacillin against S.aureus was inconclusive and (iii) no MIC could be calculated for the RG4s against E. coli. Compared to cells grown in TSB (1.89×109±4.09×108 CFU/mL), Ethanol killed 100% of the cells. Discussion: There was no significant difference between the CFU/mL for G3U and G3A2 compared to the control RNA or negative control. This may be due to the RG4s not penetrating into the bacteria despite using competent cells, bacteriostatic rather than bactericidal activity of the RG4s, or that the RG4s are labile at 37oC in E.coli. Introduction: Introduction: Occlusion of both common carotid arteries (global cerebral ischemia), followed by reperfusion, represents an animal model of stroke. NADPH oxidase (NOX) enzymes family physiologically produce reactive oxygen species. P22 is a membrane subunit present in NOX2 and NOX4 isoforms, that are strongly implicated in stroke. Hippocampus, a part of allocortex, is very sensitive to ischemia. Vitamin D has proven neuroprotective effects, while vitamin C (dehydroascorbic acid-DHA) has antioxidant activity. The aim of this experiment was to determine the effects of vitamin D and/or vitamin C on the expression of p22 subunit in different regions of Mongolian gerbil hippocampus. Methods: Methods: Animals were divided into five groups: control group; I/R (10min ischemia/24h reperfusion), I/R+vitD3 (vitamin D during 7 days before I/R); I/R+DHA (vitamin C 30 minutes before I/R) and I/R+vitD3+DHA group. Brain sections from each group were stained on microscope slides with anti-p22 antibody. Density of p22 immunopositive neurites was determined using a B36 net. The results were analysed using the one-way ANOVA with the Tukey posthoc test. Results: Results: This experiment has shown that I/R leads to significant decrease in p22 expression in dentate gyrus compared to control group (p<0,05). I/R+vitD3 and I/R+vitD3+DHA groups had an increased expression of p22 in dentate gyrus compared to I/R group (p<0,01). Discussion: Discussion: Vitamin D alone or with vitamin C, has shown protective potential and reversed changes of p22 subunit expression induced by I/R. Only p22 immunopositive neurites were counted, while p22 from glia and other brain cells were not included in this research.
A34:
A35:
The acceptability and utility of different diagnostic methods and sample types for the surveillance of trachoma in the Bijagos Islands, Guinea Bissau Ramandeep Sahota 1 , Emma Harding-Esch Introduction: Trachoma is the leading infectious cause of blindness worldwide and is hyperendemic in the Bijagos Islands, a remote archipelago of islands that lie off the coast of Guinea Bissau. Once elimination of trachoma has been achieved in the Bijagos Islands it is imperative that a successful surveillance programme is in place. The aim of this study is to determine the acceptability and utility of different diagnostic tests and sample types that could be used for trachoma surveillance. Methods: Semi-structured interviews of community members and stakeholders were followed by focus group discussions. These qualitative methods explored views on: experiences with trachoma, examining the eye for clinical signs, taking a conjunctival sample with a cotton bud, taking a blood sample, laboratory testing, health preferences within the community, and the challenges that may be faced by surveillance programmes. Results: Community members expressed dissatisfaction with their health care experiences in relation to trachoma and in some cases were keen for different procedures that would be more acceptable and useful. In general, community members and stakeholders indicated a preference for the collection of samples which can be tested in the laboratory to detect trachoma infection. Despite this, stakeholders articulated their contentment with best current practice with a trend amongst community members to ultimately be happy with whichever intervention would give them good health. Discussion: In this setting, diagnostic tests and sample types used for trachoma surveillance are accepted by communities to a degree. Appropriate sensitisation of communities prior to the implementation of a trachoma programme is crucial.
A36:
Influence of roll compaction/dry granulation on release characteristics from tablets containing an absorption modifying excipient Introduction: The desire to develop medicines with good efficacy, safety and tolerability has come at the cost of greater structural complexity -which directly impacts aqueous solubility and intestinal permeability. Absorption modifying excipients (AMEs) are among the most widely tested approaches to improve oral bioavailability of drugs with low permeability. Co-presentation of AME and active at the intestinal epithelium improves bodily absorption through the creation of a diffusion gradient, and by enabling the AME to reach a threshold concentration for flux enhancement. However, leading AMEs in development can exhibit sub-optimal dissolution, which impedes optimal presentation. Methods: This study assessed the effect of roll compaction/dry granulation on disintegration and dissolution of tablets containing two prototype actives (insulin or sodium fluorescein) and the novel AME, sodium undecylenate (C11:1). Granulates were prepared at three roll pressures (0.5, 1, and 3MPa) and two mesh sizes (8 and 12). Results: Roll compaction/dry granulation had a major effect on flowability and compressibility of mixtures. A roll force of 1MPa with a mesh size of 8 particularly, achieved a 12 (Good) on the Carr Index and the Compressibility index, compared to 37 (Very Poor) by the admixed formulation. There was no difference between dissolution, disintegration or dose uniformity between tablets made using the admixed powder versus processed granulates. Inclusion of a super-disintegrant in the formulation helped to create an immediate release dosage, that created favourable conditions for optimal permeation enhancement action. Discussion: This study shows that roll compaction/granulation parameters can be optimised to improve powder flowability and compressibility.
A37:
Recombinant expression and analysis of plasmodium falciparum erythrocyte membrane protein 1 (PfeMP1) protein domains that impact protein C pathways Giovanni Andrei Saw Ye Jeune 1 , Roger Preston Introduction: In recent studies, the protein C (PC) pathway was shown to be defective in Plasmodium falciparum-infected cerebral malaria patients. It is characterised by infected erythrocytes binding to the endothelial cell protein C receptor (EPCR) within the cerebral vasculature. Moreover, P. falciparum erythrocyte membrane protein 1 (PfEMP1), was shown to bind to EPCR with 200-fold higher affinity than that described for APC (KD~0.3nM). PfEMP1 variants containing cysteine-rich inter-domain region, CIDRα1.1 and 1.4-1.8 domains, bind EPCR at a similar site to PC/APC, but with higher affinity. This study aims to generate CIDRα1 domains for functional analysis of their impact on PC/APC binding and cell signalling. Ultimately, this study will enable the generation of tools to regulate this interaction and inhibit vascular pathogenesis caused by P. falciparum-infected individuals with cerebral malaria.
Methods: This will be achieved by cloning a synthetic gene fragment encoding a His-tagged CIDRα1.4 domain into an E. coli protein expression plasmid to be used for recombinant expression, purification and molecular analysis.
Results: The CIDRα1.4 protein was generated and successfully expressed in the transformed E. coli cells. This was confirmed using Western blot analysis, in which an anti-His HRP-conjugated antibody detected CIDRα1.4 at the anticipated molecular weight of 40kDa.
Complete purification of the CIDRα1.4 protein proved challenging despite altering the concentration of Imidazole in the wash and equilibration buffer. Discussion: We were successful in expressing a synthetic gene fragment encoding the CIDRα1.4 domain. The complete purification of this recombinant protein requires further optimization prior to molecular analysis with EPCR.
A38:
Investigating the therapeutic potential of BET inhibitor JQ1 in models of invasive ductal carcinoma ( Introduction: Studies have shown that BET inhibitors have antitumor activity against various solid tumors, including tamoxifen resistant breast tumors. This study aimed on investigating the therapeutic effects for single and combined therapy of BET inhibitor JQ1 and tamoxifen on both IDC and ILC cell lines. Methods: Following molecular characterization, the MCF7 and CAMA1 models were selected from a panel of breast cancer cell lines. For single-agent treatments, cells were treated with the established IC50 of each inhibitor for 72 hours, followed by the MTT assay to establish cellular viability. For combination treatments, cells were treated with varying doses of each inhibitor, and the MTT assay was again employed to establish cellular viability. Western blotting was used to examine PARP cleavage as an indication of JQ1 activity and progesterone receptor to examine tamoxifen activity. Results: For single therapy, MCF7 showed moderate response to JQ1, but CAMA1 cells were more resistant. For the dual-agent "synergy" assay, synergy between JQ1 and tamoxifen was demonstrated in the MCF7 cells at high doses. Modest synergy was demonstrated in the CAMA1 cells. PARP cleavage following JQ1 treatment, as well as the combination treatment, was demonstrated in the MCF7 cell line. Furthermore, there was down regulation of progesterone receptors with tamoxifen and JQ1 for both cell lines. Discussion: This study showed that MCF7 are more sensitive to BET inhibitor JQ1 compared with CAMA1. Although it was a small study, the results were promising. For future work, we aim on increasing our sample size and use JQ1 on tamoxifen-resistant cells. Introduction: Snus users are not fully informed about the possible harmful effects on the health from its use due to lack of information in Latvia. This paper examines whether there is any relevance between smokeless tobacco intake, periodontal diseases and oral malignity. Methods: Using a questionnaire about smokeless tobacco consumption a heavy snus group, a light snus group and a control group were made. Oral biopsy samples were collected from heavy and light group snus users, and immunohistochemically tested for Ki67, PGP 9.5, CAB, IL-1, IL-10. Periodontal pocket biofilms were collected from all groups and tested with RT-PCR. They were further analysed in order to determine the presence of pathogenic periodontal bacteria A. actinomycetemcomitans, P. gingivalis, T. forsythia, T. denticola and P. intermedia. The quantity of bacteria was expressed by the reference interval Lg/equivalents/sample. Statistical analyse made by the Mann-Whytney U test.
Results:
Biopsy results showed parakeratosis, epithelial disorganization, vacuolization with prevalence of keratotic seborrhea, oral ulcerations. PGP 9.5 marked epitheliocytes, nerve fibres, fibroblasts were detected. Ki67 basal epitheliocytes were viewed. IL-10 was possessed in the epithelium. Il-1, CAB were absent. Microbiological examination showed presence of periodontal pathogens in heavy and light snus users group (p<0.05) but in the control group presence of periodontal pathogens were statically not significant (p>0.05). Discussion: Smokeless tobacco spurs the persistent proliferation potential in the epithelium. Smokeless tobacco intake is related to periodontal diseases and can be associated with oral malignity. This study could build awareness in young adults about smokeless tobacco's harmful effects.
A40:
Characterisation of CPEB-1 in relation to epilepsy Sarita Ankatiah 1 , Tobias Engel 2 , Laura de Diego-García Introduction: Epileptogenesis is the process by which the normal brain undergoes changes, resulting in spontaneous recurrent seizures or epilepsy. Cytoplasmic polyadenylation element binding proteins (CPEBs 1-4) regulate cytoplasmic polyadenylation and translation through poly(A) tail elongation or repression and have been implicated in synaptic plasticity, long-term potentiation, learning and memory, processes affected during epileptogenesis. Since the association between cytoplasmic mRNA polyadenylation and epilepsy has yet to be investigated, this project aims to determine its role in status epilepticus (SE) and epilepsy. Methods: Status epilepticus and chronic epilepsy were induced via intra-amygdala kainic acid injection and the mice were sacrificed after 1 hour, 24 hours and 14 days. Hippocampal CPEB1 expression was quantified using western blot, and sagittal hippocampal slices were examined by immunohistofluorescence to determine CPEB1 location. Results: CPEB1 in the hippocampus demonstrated an increased expression after inducing SE. Even though the biggest increase in expression was observed after 4 hours and 24 hours, these results are not statistically significant. In the dentate gyrus of the hippocampus, CPEB1 was mainly expressed in microglia after 1 hour, 24 hours and 14 days post-SE, but not in neurons or astrocytes. Interestingly, in the cortex, CPEB1 was expressed in both microglia and neurons, with the most significant expression in neurons 1 hour and 24 hours after SE. Discussion: An association exists between cytoplasmic mRNA polyadenylation and epilepsy, which requires further investigation to determine the nature of the interaction. The presence of CPEB1 in microglia may play a role in regulating gene expression related to neuroinflammatory processes during seizures.
A41:
Radiotherapy in the elderly; do they receive and tolerate the same treatment as younger patients with cancer? Claire Conlon 1 , Lorna Keenan Introduction: The National Cancer Strategy for Ireland has identified that older patients with cancer are less likely to have tumour directed treatment versus younger patients. In order to evaluate radiotherapy provision, we detail the pattern of use of radiation oncology services by patients over 70 years of age and compare this to patients under 70 years of age. Methods: This study includes patients aged >70, with a cancer diagnosis within the central nervous system, head and neck, lung, gastrointestinal and gynaecological categories. All patients seen for initial consultation in 2015 in our national cancer centre were included. Data on treatment intent and outcomes were prospectively collected via an automated database. A subset of patients aged <70 were analysed for comparison. Results: 501 patients over 70 years of age were seen for radiotherapy opinion. The majority (85%) were treated, 67% with radical intent and 33% with palliative intent. Of the total population seen, <5% were not recommended for treatment because they were deemed unfit. Breaks in treatment due to toxicity were observed in <5% and treatment was discontinued in 2%. Patients under 70 (n=104) had similar overall treatment patterns and completion rates. Discussion: The majority of older patients who were referred for consideration of radiotherapy were treated and completed treatment in a similar manner to younger patients. This demonstrates the successful treatment of older patients without exerting a burden of delayed or incomplete treatment and provides useful evidence to support the provision of tumour directed treatment for older patients. Introduction: Chronic subdural haematomas (CSDH) are one of the most common pathologies caused by head trauma, which leads to subdural bleeding with hematoma formation and symptoms, such as, headaches, neurological symptoms, or coma. For a long time the double Burr holes (DBH) procedure was and is the "gold standard treatment" for CSDH, however our prospective study focuses on the single Burr hole (SBH) procedure and its benefits. Therefore, does the single Burr hole procedure compared to the double Burr hole procedure provide better outcomes for both the patient and the surgeon? Methods: 10 patients were treated for CSDHs by the (SBH) procedure with one hole and incision in the region of the parietal tuber. Patients presented with raised (ICP) and varying degrees of hemiparesis. The inclusion criteria only required the absence of multiple septal barriers in subdural space, identified by CT. A drain was left in the subgaleatic space for 48 hours post operatively. Results: The postoperative period was uneventful with neurological symptom regression and no seizures. When discharged on the third postoperative day patients were instructed to consume antiepileptics for 7-14 days, perform follow up CTs at intervals of 7 then 30 days post operatively. The (SBH) approach showed the same clinical and radiologic results in the selected group of patients as in patients who underwent the (DBH) procedure. Discussion: (SBH) should be option one for patients without septal barriers and patients undergoing anticoagulation therapy, due to; a shorter surgery, one cranial opening, same clinical and radiological results and a better cosmetic outcome.
A43:
The need for emergency care education: High school students' exposure to health emergencies affecting confidence in emergency situations E Chin Mak 1 , Henry A Curtis Introduction: Laypersons are often bystanders of medical emergencies and are crucial to initiating immediate first aid. Education and training in emergency care therefore encourage laypersons to provide more efficient and fluent first aid at emergencies. Emergency care curriculums are often an optional course where students can choose not to participate in. However, training encourages fluidity of responding to health crises, allowing students to overcome inhibitors of providing help, like unfamiliarity, feeling scared and presence of other spectators, leading to higher helping rates . The study questions whether past experience in medical emergencies affect the student's perceived comfort levels in providing immediate care. The interest in first-aid education amongst high school students is also explored. Methods: High school students completed a survey for prior medical emergency experiences, comfort levels in assisting with multiple emergent situations and willingness to respond. Perception of the value of future first aid training was collected using a 10-point scale. Chi square tests were used for data analysis. Results: Chi square tests showed association between past experience and comfort in assisting with medical care (p<0.001). The importance of school first aid training scored an average of 8.0 and 9.2, amongst the students with and without experience respectively. Discussion: Those with prior experience in medical emergencies generally report higher comfort levels in assisting with urgent medical care, suggesting value in first aid training. The implementation of such training in high school curriculums provides exposure from an early age, aiding to overcome inhibitors and raise helping rates. Methods: This is a secondary analysis of The Prospective Observational Trial to Optimize Paediatric Health. This study recruited 1,200 singleton pregnancies with EFW <10th centile. Pregnancies underwent serial sonographic assessment of fetal weight and multi-vessel Doppler studies. Eight formulae developed specifically for SGA fetuses or low birthweight (LBW) infants were compared, in addition to the Hadlock III & IV (1985) and Intergrowth-21st (2017) formulae. The accuracy of formulae was assessed using percentage error and a prediction model was used to account for growth during the interval to delivery. Results: Complete fetal biometry within one week of delivery was available in 588 pregnancies. The mean birthweight was 2,311g (SD= 647g) and the median GA at delivery was 37.7 weeks (range=26.4-42.6 weeks). The Hadlock III, IV and Sabbagha III formulae all had almost no systematic bias. All three formulae had similar random errors (Interquartile range: 10-13%) and had the highest proportion of EFW within 10% of birthweight (77%). Percentage error was dependent upon both GA at scan (p<0.001) and time interval to delivery (p<0.001). The use of projection to delivery methods improved the accuracy of the other formulae but did not change the conclusions. Discussion: Our study, which recruited pregnancies with EFW < 10th centile (Hadlock IV, 1985) suggests that there is no benefit to subsequently switching to formulae targeted for the SGA fetus or LBW infant.
A45:
Hadlock vs. Skupski: Estimating gestational age in twin pregnancies using NICHD standard (Skupski 2017 Introduction: To assess the performance of the new NICHD formula for gestational age (GA) determination in a twin population. Methods: This is a secondary analysis of the ESPRiT Study. Two subgroups of the ESPRiT cohort were used for GA determination, and had full biometry assessments in the 2nd and 3rd trimesters. (1) IVF/ ICSI-conceived pregnancies (120) (2) Non-IVF pregnancies with Crown-Rump Length (CRL) assessed in the first trimester (276) Comparisons were made between IVF embryo-transfer-date (ETD) versus CRL-dating, ETD and later pregnancy biometry-dating and CRL, via Hadlock (1992) and later pregnancy biometry dating via Hadlock (1984) and NICHD/Skupski (2017). GA accuracy estimation was via the mean (systematic error) & SD (random error) of differences in GA. Results: The NICHD formula systematically underestimates GA in twin pregnancies by 1-2 weeks in the 2nd and 3rd trimesters in IVF and spontaneously conceived twin pregnancies, resulting in more spontaneously conceived pregnancies being re-classified as sub-optimally dated. In the IVF population, 1st trimester CRL dating was more accurate in the smaller (CRL) twin, overestimating gestational age by 2-3 days on average. Both smaller and larger twins performed well using later pregnancy biometry dating (Hadlock) in the 2nd & 3rd trimesters, with the average twin gestation having minimum errors. In the spontaneous conception population with CRL assessments, the larger (EFW) twin performed the best in the 2nd and 3rd trimesters using fetal biometry. Discussion: The NICHD method for gestational age determination cannot be recommended as an alternative to the Hadlock (1984) method in the 2nd/3rd trimester for twin pregnancies. Introduction: ST-segment Elevation Myocardial infarction (STEMI) is one of the leading causes of death worldwide. International guidelines clearly state that Primary Percutaneous Coronary Intervention (PPCI) is the gold standard of treatment. However, due to a lack of cardiac catheterisation services, many patients receive thrombolytic therapy at a non-interventional hospital before being transferred to a PCI capable hospital. This single centre observational study investigated the efficacy and safety of Pharmacoinvasive Strategy (PIS) versus PPCI in the context of the Romanian National STEMI program. Methods: From January 1st -May 31st 2018 forty-seven consecutive patients from surrounding county hospitals were enrolled in this study and divided into two groups; The first group underwent thrombolysis in the first contact hospital before being referred to our PCI center (PIS group) while the second group was transferred directly for PCI (PPCI group).
A46:
Results: Cardiovascular risk factors were present in the vast majority of patients with no major differences between the two groups. Left ventricular systolic dysfunction (LVEF less than 40%) was more frequent in the PPCI group. The number of diseased vessels including the culprit lesion was similar in both groups. In-hospital deaths, length of hospital stay and in hospital MACE were higher in the PPCI group, than in the PIS group. Discussion: PIS had better outcomes than PPCI when long distances to catheterization labs exist. The results suggest that thrombolysis should be performed in non-PCI centers with referral to a 24/7 PCI capable hospital as soon as possible. PIS is a viable alternative that saves lives.
A47:
Are ER+ breast cancer cells de novo resistant or do they acquire their resistance to Tamoxifen Introduction: Breast cancer is one of the leading causes of death in women. Anti-endocrine therapies such as Tamoxifen are often used to treat it. However, 30% of them develop resistance, posing a significant challenge clinically. Early events in endocrine resistance are poorly understood. Previous work in this lab has identified SSEA1+ cells as drivers of tamoxifen resistance in ER+ breast cancer. It was found that these cells were not de novo resistant, but rather acquired this feature. This led us to asking '' Are ER+ breast cancer cells in additional tissue culture models and patient tissue samples de novo resistant or do they acquire their resistance to Tamoxifen therapy?" Methods: Tissue culture and flow cytometry was performed on the T47D cell line in vehicle, estrogen and estrogen and Tamoxifen. The cells were subsequently stained with DCO and anti-SSEA1-APC to measure progress through the cell cycle with respect to SSEA1 marked sub-populations. Immunohistochemistry/Immunofluorescence was also performed using primary and secondary antibodies against SSEA1 and Ki-67. Results: Analysis of the T47D cell line confirmed the previous findings that SSEA1+ cells are not de novo resistant. Unfortunately, there was insufficient proliferation in ex vivo tumour samples to confirm or reject the hypothesis. Discussion: This study has helped in understanding this particular cell type (SSEA1+)that drives endocrine resistance in breast cancer. RNA sequencing could further be employed to understand key genes that differ between SSEA1+ and SSEA-cell types which could potentially be used as biomarkers of prognosis or targets of therapy in the future.
A48:
Prevalence of Diabetes Mellitus secondary to pancreatic diseases (type3cDM): A 13-year retrospective cohort study in a university hospital Kameron Chatoor Introduction: The American Diabetes Association (ADA) classified Diabetes Mellitus (DM) secondary to pancreatic diseases as Type3cDM. Typically, Type3cDM occurs in patients with chronic/acute pancreatitis, pancreatic cancer, and pancreatic surgery. However, due to poor awareness, Type3cDM patients are frequently misclassified as type 1/2 DM, and may therefore be mismanaged. We aimed to crossmatch a large DM database with a pancreatic disease database to determine how many patients had both pancreatic disease and DM, and to identify how many patients had a diagnosis of DM following pancreatic disease, suggestive of type3cDM.
Methods: This was a retrospective observational study. For a 13-year period (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) (2017) the Department of Surgery Pancreatic Database (PD) and Diamond Diabetes Database (DDD) in Tallaght University Hospital were cross-matched for common patients. Results: The DDD had 12,000 patients for 2004-2017, while the PD had 2,048 patients. Cross-matching showed that there were 287 common patients with both pancreatic disease and DM. Of these, 194 patients (67.6%) were diagnosed with DM after pancreatic disease diagnosis, suggestive of true type3cDM. However, only 56 patients (19.5%) had been classified as type3cDM. The most common aetiology was acute pancreatitis (45%). For the remaining 231 patients, 192 (66.9%) were Type 2 and 39 (23.5%) Type 1. Discussion: While more than half of patients were thought to have Type3cDM they had not been classified as such, despite ADA guidelines. Type3cDM is difficult to manage, particularly when coupled with the other complications of pancreatic diseases, such as malabsorption. Correct classification would allow optimal management, and improved disease understanding. Introduction: Peripherally Inserted Venous Catheters (PIVC) are most often used to facilitate the administration of intravenous (IV) medications or fluids. We present a prospective clinical audit on IV cannula use from 3 surgical wards, AB Clery, Phoenix and Finbar's Day Ward, at Beaumont hospital, in order to assess adherence to local hospital guidelines, from which our standards were derived. Methods: We collected data from 100 patients over a period of 6 weeks, from 8th January 2018 to 16th February 2018. Handwritten raw data was transcribed onto a Microsoft Excel spreadsheet and processed into relevant graphs and figures. Results: We found that 96% of our cohort had a documented indication for cannula insertion, 79% of cannulas were inserted into distal veins, 62% of cannulas had an insertion and removal date documented, 65% of cannulas were removed within 72 hours, 23.5% of cannulas sited in emergency situations were removed with 24 hours and 66.7% of cannulas with signs of phlebitis were removed in 24 hours. Discussion: We have recommended IV cannula review on every ward round, allowing cannulas inserted in A&E to remain for 72 hours in the absence of signs of phlebitis, and requesting nurses to prompt a medical review of a cannula that has been in-situ for 72 hours. We have made a poster to better implement these recommendations. We further recommend performing a re-audit with the above changes to identify any quality improvement. School of Medicine, RCSI, Dublin, Ireland; 2 University Hospital Erlangen, Immunology and Rheumatology, Medical Clinic 3, Erlangen, Germany Correspondence: Erica O'Sullivan BMC Proceedings 2019, 13(Suppl 6):A50: A Introduction: SLE, an inflammatory autoimmune disease involves auto-antibodies, immune-complex deposition and multi-organ damage. Diagnosis includes Anti-Nuclear-antibody testing (Sensitive, not specific for SLE), followed more specific autoantibody testing (double-stranded-DNA (dsDNA), Ro, La, U1-Ribonucleoprotein). A deficiency of apoptotic cell-clearance plays an important role in the pathogenesis of SLE, thus complement pathway deficiencies confer a higher risk. We aimed to develop a highly specific test, utilizing secondary-Necrotic-cell (SNEC)-derived material as a substrate, for the detection of SLE-autoantibodies (AAb) and compare SNECs derived from whole-blood to cultured-cells. Methods: Ethical-approval' obtained. Serum collected from Normal/ Healthy Donors (NHD), patients with SLE, other auto-immunedisorders (OAD). Peripheral-Blood-Mononuclear-cells (PBMCs) isolated from whole-blood. Jurkat-cells cultured. Apoptosis induced by UVradiation. Anti-SNEC-AAb measured in serum of SLE (n=155), NHD (n=89), OAD (n=169) using SNEC-based indirect enzyme-linked immunosorbent assay (SNEC-ELISA). SNEC-ELISA compared to routine anti-dsDNA diagnostics: radioimmunoassay (RIA) and nucleosomebased-ELISA (NcX-ELISA). SNEC-derived from whole-blood (primary-SNEC) compared to cultured cells (jurkat-SNEC). Results: Primary-SNEC-ELISA distinguished SLE with 98.9% specificity and 70.6% sensitivity from NHD; surpassing Jurkat-SNEC (98.25%, 43.37%), anti-dsDNA: RIA (97.6%, 37.9%)/ NcX-ELISA (98.4%, 43.1%). Positive Anti-SNEC-AAbs on SNEC-ELISAs discriminated SLE from rheumatoid arthritis, anti-phospholipid syndrome, spondyloarthropathy and systemic sclerosis. Discussion: Primary-SNEC-ELISA detects SNEC-AAb in SLE-Serum with high sensitivity and specificity, surpassing current autoantibody testing in routine diagnostics. Stressing SNECs role in SLE-pathogenesis and potential for Diagnosis/Monitoring. A new cohort of NHD-Serum samples were compared between Jurkat-SNEC and Primary-SNEC. Additionally, Jurkat-Cells are Immortalised T-cells, thus distinct from Primary-PBMCs. This may explain the difference in assay sensitivity between primary-SNEC and Jurkat-SNEC. Future Research can optimise SNEC-ELISAs and further standardise testing.
A51:
An audit on IV cannula use on the surgical wards of Beaumont Hospital Hiba Makhdum Introduction: Peripheral intravenous cannulation (PVC) can be associated with multiple complications. Various criteria are taken into account in the care of PVCs in order to minimise these complications. This study was conducted to evaluate the compliance rates and the significance of these criteria. Methods: A standards-based clinical audit was conducted on the two surgical wards of Beaumont Hospital. Standards and criteria were set by the Beaumont Hospital policy on insertion and maintenance of PVCs. A cohort of 104 cannulas was collected over a 6-week period. Microsoft Excel was used to compile and analyse the data. Results: 40% of cannulas inserted on the ward were removed within 72 hours. 3% of cannulas inserted in an emergency setting were removed within 24 hours. Early signs of phlebitis were present in 6% of cannulas changed within 72 hours, 9% of cannulas left in for longer than 72 hours and 3% of emergency setting cannulas left in for longer than 24 hours. Early stages of phlebitis were seen in 1% of the audited cannulas. Discussion: 1. PVCs inserted on the ward may remain in-situ up to 96 hours, provided there are no clinical signs of phlebitis. 2. PVCs inserted in an emergency setting may remain in-situ up to 72 hours, provided there are no clinical signs of phlebitis. 3. A cannula should be checked a minimum of once daily and this should be documented. 4. Regular cannula care awareness teaching sessions should be conducted as well as yearly cannula care audits.
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Drug utilization study in epilepsy in a tertiary care hospital Nethmie Chandrarathna Introduction: Pharmacotherapy in epilepsy requires the drugs to be taken for a long time. These drugs have a negative impact on cognition, are potentially teratogenic and considered to be not so safe. Moreover, to remain seizure free, the patient often requires more than one drug. Additionally, these patients would also require drugs other than antiepileptics in presence of concomitant illnesses. Such polypharmacy comes with its own drawbacks like higher incidences of drug interactions, adverse effects and increased economic burden on the patient. In the current study, we analysed the drug utilization pattern in different types of epilepsy including the extent of polypharmacy Methods: Prescriptions of 100 epileptic patients admitted in a tertiary care hospital were scrutinised. Descriptive statistics was used to analyse the data Results: Sample consisted of 66 paediatric and 34 adult patients. The most frequent type of epilepsy encountered was generalised tonicclonic seizures. Commonest antiepileptic drug (AED) prescribed was phenytoin (40%) and levetiracetam (38%) was the most frequent add-on drug. The average number of drugs prescribed to the patients was 6 which included drugs given for concomitant illnesses as well. Most of the patients (62%) required multiple antiepileptic drugs for seizure control Discussion: It is evident from this study that epileptic patients are subjected to a large number of drugs which puts them at a risk of potential drug interactions and adds to the cost of treatment. Hence, rational prescription should be encouraged and the use of each drug should be justified. Introduction: Epilepsy is a disease characterized by abnormal neural activity in the brain which cause seizures. What gene changes underlie epilepsy development, however, are incompletely understood. Thus, the purpose of this study is to identify genes which change their expression during acute seizures (status epilepticus) and chronic epilepsy. Methods: To identify these genes we injected kainic acid into the amygdala of mice a to induce status epilepticus. The hippocampi were collected at two time-points: 8 hour (8 h) after status epilepticus (acute phase) and at 14 day (14 d) after status epilepticus when all mice experience epileptic seizures. A control group was also present. Using microarray we were able to identify the upregulated and downregulated genes in both 8h and 14 d samples. Next, KEGG pathway analysis was performed to identify relevant cascades. Finally, RT-qPCR was carried to validate the most significant genes. Results: Upon many upregulated and downregulated genes, our results show a significant downregulation of the ITPR1 gene in 14 d samples in relation to the control group. Furthermore, KEGG pathway analysis revealed the physiological role of ITPR1 in the calcium signaling pathway. Discussion: Our data offers new insight towards abnormal gene expression in epilepsy. The downregulation of ITPR1 gene in epilepsy may serve as a negative feedback loop to counteract increased hyperexcitability.
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PAD2 enhances airway degradation due to MMP-12 in emphysema Rashed Alshuhoumi 1 , Emer Reeves
